DK0628558T3 - Fremgangsmåde til syntese af 9-(2-hydroxyethoxymethyl)-guanin - Google Patents

Fremgangsmåde til syntese af 9-(2-hydroxyethoxymethyl)-guanin

Info

Publication number
DK0628558T3
DK0628558T3 DK94108426T DK94108426T DK0628558T3 DK 0628558 T3 DK0628558 T3 DK 0628558T3 DK 94108426 T DK94108426 T DK 94108426T DK 94108426 T DK94108426 T DK 94108426T DK 0628558 T3 DK0628558 T3 DK 0628558T3
Authority
DK
Denmark
Prior art keywords
guanine
synthesis
hydroxyethoxymethyl
acyclovir
subject
Prior art date
Application number
DK94108426T
Other languages
English (en)
Inventor
Tiberio Bruzzese
Giuseppe Guazzi
Marco Rognoni
Giuliano Marcon
Original Assignee
Solchem Italiana Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solchem Italiana Spa filed Critical Solchem Italiana Spa
Application granted granted Critical
Publication of DK0628558T3 publication Critical patent/DK0628558T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94108426T 1993-06-14 1994-06-01 Fremgangsmåde til syntese af 9-(2-hydroxyethoxymethyl)-guanin DK0628558T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001264A IT1264599B1 (it) 1993-06-14 1993-06-14 Processo per la sintesi della 9-(2-idrossietossimetil)- guanina

Publications (1)

Publication Number Publication Date
DK0628558T3 true DK0628558T3 (da) 1999-02-08

Family

ID=11366388

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94108426T DK0628558T3 (da) 1993-06-14 1994-06-01 Fremgangsmåde til syntese af 9-(2-hydroxyethoxymethyl)-guanin

Country Status (7)

Country Link
US (1) US5496945A (da)
EP (1) EP0628558B1 (da)
AT (1) ATE165096T1 (da)
DE (1) DE69409578T2 (da)
DK (1) DK0628558T3 (da)
ES (1) ES2117172T3 (da)
IT (1) IT1264599B1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276126B1 (it) * 1995-11-14 1997-10-27 Archimica Spa Procedimento per la preparazine di 9-((2-idrossietossi)metil) guanina
CN103601768B (zh) * 2013-11-13 2015-09-30 齐鲁天和惠世制药有限公司 一种阿米卡星的制备方法
CN107903268A (zh) * 2017-11-16 2018-04-13 湖北省宏源药业科技股份有限公司 一种阿昔洛韦的提纯方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
DK135489D0 (da) * 1989-03-20 1989-03-20 Gea Farmaceutisk Fabrik As Fremgangsmaade til fremstilling af 9-substituerede guaninderivater og mellemprodukter til brug ved fremgangsmaaden
JP3225545B2 (ja) * 1991-09-18 2001-11-05 味の素株式会社 非環状ヌクレオシド類の製造法

Also Published As

Publication number Publication date
EP0628558B1 (en) 1998-04-15
ITMI931264A1 (it) 1994-12-14
ITMI931264A0 (it) 1993-06-14
DE69409578D1 (de) 1998-05-20
ES2117172T3 (es) 1998-08-01
US5496945A (en) 1996-03-05
ATE165096T1 (de) 1998-05-15
IT1264599B1 (it) 1996-10-04
DE69409578T2 (de) 1998-11-19
EP0628558A1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
PH30150A (en) Method of producing 7-(substituted)-9-[(substituted glycyl) amido]-6-dimethyl-6- deoxytetracyclines
DK1028940T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DE69324923D1 (de) Antiretrovirale, enantiomere Nukleotid-Analoge
EA199700124A1 (ru) Производные гуанина
FI942161A0 (fi) Menetelmä 5-metyyli-tetrahydrofoolihapon erottamiseksi
ATE158798T1 (de) Verfahren zur herstellung von optisch aktiven zyklobutannukleosiden
MX17846A (es) Proceso para la preparacion de nuevos derivados de 9h purina.
CA2149886A1 (en) Process for preparing tetrazolyl-benzopyranones
DK0538345T3 (da) Fremgangsmåde til fremstilling af haloidglasemner
DK0503453T3 (da) Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
DK0704445T3 (da) Fremstilling af N-9-substituerede guaninforbindelser
DK0628558T3 (da) Fremgangsmåde til syntese af 9-(2-hydroxyethoxymethyl)-guanin
ATE201201T1 (de) Verfahren zur herstellung von pyrimidinderivaten
DK0407212T3 (da) Enantioselektiv syntese af antifolater
TW216794B (da)
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
MX9701569A (es) Pirimidin(tio)onas substituidas.
DK303987A (da) Fremgangsmaade til syntese af n-amino-3-azabicyklo oe3,3,0aa octan
ITMI922432A1 (it) Procedimento per la preparazione di diltiazem
TR199500894A2 (tr) Antiviral guanin türevi 9-(2-hidroksietoksimetil)-guanin 'in sentezi icin yöntem.
DK0647624T3 (da) Mellemprodukter til fremstilling af A-vitamin og carotenoider samt fremgangsmåder til fremstilling deraf
DK36689A (da) Fremgangsmaade til fremstilling af et 16-methoxy-16-methyl-prostaglandin e1-derivat, samt ved fremgangsmaaden anvendelige mellemprodukter
DK0534536T3 (da) Fremgangsmåde til fremstilling af 2-amino-5,6-dimethoxy-tetralin
ATE108767T1 (de) Acyclische terpene.
ATE169908T1 (de) Verfahren zur herstellung von gegebenenfalls 2- substituierten 5-chlorimidazol-4-carbaldehyden